Evidence map›Paper›PMID 27982096›Full record

ArticleScientific reports2016

A structural insight into the negative effects of opioids in analgesia by modulating the TLR4 signaling: An in silico approach.

Masaud Shah, Muhammad Ayaz Anwar, Dhanusha Yesudhas, Jayalakshmi Krishnan, Sangdun Choi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Stereochemistry and innate immune recognition: (+)-norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signaling.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Masaud ShahDepartment of Molecular Science and Technology, Ajou University, Suwon, 443-749, Korea.
Muhammad Ayaz AnwarDepartment of Molecular Science and Technology, Ajou University, Suwon, 443-749, Korea.
Dhanusha YesudhasDepartment of Molecular Science and Technology, Ajou University, Suwon, 443-749, Korea.
Jayalakshmi KrishnanDepartment of Life Sciences, Central University of Tamil Nadu, Neelakudi, Thiruvarur, Tamil Nadu, India.
Sangdun ChoiDepartment of Molecular Science and Technology, Ajou University, Suwon, 443-749, Korea.
Ajou University · KRCentral University of Tamil Nadu · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Opioids are considered the gold standard therapy for pain. However, TLR-dependent negative effects in analgesia have highlighted the complexities in the pharmacodynamics of opioids. While successive studies have reported that morphine and Morphine-3-glucuronide (M3G) activate the TLR4 pathway, the structural details of this mechanism are lacking. Here, we have utilized various computational tools to reveal the structural dynamics of the opioid-bound TLR4/MD2 complex, and have proposed a potential TLR4 activation mechanism. Our results support previous findings, and include the novel insight that the stable binding of morphine and naloxone, but not M3G, in the MD2 cavity, is TLR4 dependent. Morphine interacts with MD2 near its Phe126 loop to induce the active conformation (MD2

Indexed as

Analgesics, OpioidAnimalsBinding SitesHydrogen BondingLigandsLymphocyte Antigen 96Molecular ConformationMolecular Docking SimulationMorphineMorphine DerivativesNaloxonePrincipal Component AnalysisProtein BindingProtein Structure, TertiarySignal TransductionThermodynamicsAnalgesics, OpioidLigandsLy96 protein, mouseLymphocyte Antigen 96Morphinemorphine-3-glucuronideMorphine DerivativesNaloxoneToll-Like Receptor 4

Identifiers

PMID27982096
PMCPMC5159903
OpenAlexW2562507245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.